NEW YORK (GenomeWeb News) – WaferGen Biosystems has raised gross proceeds of approximately $6.2 million through a series of private placements between June 16 and Aug. 31, the firm said today.

The publicly traded maker of gene expression and genotyping systems said that it issued roughly 5 million shares of common stock at a price of $1.25 per share, along with warrants to purchase 1,502,700 shares of common stock, at an exercise price of $2 per share. The warrants have a five-year term, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.